DementiaNCT06888713
Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults With Cognitive Deficits
A study testing Telemonitoring of ADL in people with Dementia, run by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal at 3 sites in Canada.
Trial summary
In Canada, it is estimated that two million people are users of publicly funded home care services, with more than half of them being 65 years and older. Although home care services are considered a priority by Canadian provinces, in Québec alone, more than 46 000 people were waiting for those services in 2022. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Dementia
- What is being tested?
- Telemonitoring of ADL
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 3 sitesCanada
- Study dates
- 1 Apr 2025to 31 Dec 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- 1) be an older adult (> 65 years old), 2) have cognitive deficits as reported in the medical record, 3) live alone, at home, 4) be a care recipient of home care services, 5) speak French or English
Who cannot join
- None
Trial locations and contacts
3 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Canada3 sites, 3 recruiting
- Recruiting
CIUSSS Centre-sud-de-l'île-de-Montréal
Montreal, Quebec
Nathalie Bier, 5149094483, nathalie.bier@umontreal.ca
- Recruiting
CIUSSS de l'Est-de-l'île-de-Montréal
Montreal, Quebec
Nathalie Bier, 5149094483, nathalie.bier@umontreal.ca
- Recruiting
CIUSSS Saguenay-Lac-St-Jean
Montreal, Quebec
Nathalie Bier, 5149094483, nathalie.bier@umontreal.ca
About this study
Official title: Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults With Cognitive Deficits: a Large-scale Action Design Research Study
In Canada, it is estimated that two million people are users of publicly funded home care services, with more than half of them being 65 years and older. Although home care services are considered a priority by Canadian provinces, in Québec alone, more than 46 000 people were waiting for those services in 2022. The provision of home care services is hampered by limited funding and growing demand from among an aging population, among other factors. These challenges have led to urgent calls to better support home care in Canada to ensure optimal use of scarce human and financial resources. One of the key strategies to achieve optimal use of resources may be remote monitoring of activities of daily living (ADLs), a type of telehealth. ADL telemonitoring can remotely recognize ADLs such as preparing meals and moving around the home. Past studies have shown that ADL telemonitoring can help in better understanding older adults' home care needs, thereby allowing for more personalized ADL interventions. Previous projects have also allowed for the developement of NEARS-SAPA, a telemonitoring system for ADLs. In these past projects, it was identified how NEARS-SAPA was used by home care services and its ease of use was tested in real environments. In the present project, the benefits of ADL telemonitoring will be tested and its technological capabilities expanded, hence preparing the system for the next big step, i.e. large-scale adoption by home care services. Ultimately, ADL telemonitoring may help the healthcare system determine which service is more appropriate for which person and at what time, thereby optimizing interventions and resource management.
- Conditions
- Dementia
- Being tested
- Telemonitoring of ADL
- Keywords
- Telemonitoring of ADL, Homecare services, IA
- Medical subject headings
- Dementia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Telemonitoring of ADLOther
Telemonitoring of ADL is based on smart environments sensors (non wearables) and gathers information about activity of daily living routines for a better understanding of homecare services needed.
| Study group | Role | What they receive |
|---|---|---|
| Telemonitoring of ADL group | Experimental | Will receive the technology in their home to document if it influenced the homecare services plan. Receives: Other: Telemonitoring of ADL |
| No telemonitoring of ADL | No intervention | Another group will be followed in therms of homecare services received, but without the technology. The control group will be gathered based on archives data only. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of homecare services received to support activities of daily living (ADL)
Number of homecares ADL services received as identified in clinical databases.
Measured: From enrollment until around 12 months of following.
Nature of homecare services received to support activities of daily living (ADL).
The category of services received related to ADL as indicated in clinical databases.
Measured: From enrollement until around 12 months of following.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Mar 2025
- Study start1 Apr 2025
- Primary completion1 Apr 2028 (estimated)
- Study completion31 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DementiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nathalie Bier, Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
- Investigators
- Nathalie Bier, Ph.D., Principal investigator, CRIUGM, Université de MontréalCharles Gouin-Vallerand, Ph.D., Principal investigator, Université de SherbrookeKevin Bouchard, Ph.D., Principal investigator, Université du Québec à Chicoutimi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06888713
- Sponsor's protocol ID
- PJT-195697
- Status last verified
- Oct 2026
- First submitted
- 28 Feb 2025
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 22 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults With Cognitive Deficits: a Large-scale Action Design Research Study
- ClinicalTrials.gov ID
- NCT06888713
- Acronym / sponsor ID
- PJT-195697
- Conditions
- Dementia
- Keywords
- Telemonitoring of ADL, Homecare services, IA
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Centre de Recherche de l'Institut Universitaire de Geriatrie de MontrealUniversity, hospital or other
- Study start
- 1 Apr 2025 (actual)
- Primary completion
- 1 Apr 2028 (estimated)
- Study completion
- 31 Dec 2028 (estimated)
- First posted
- 21 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In Canada, it is estimated that two million people are users of publicly funded home care services, with more than half of them being 65 years and older. Although home care services are considered a priority by Canadian provinces, in Québec alone, more than 46 000 people were waiting for those services in 2022. The provision of home care services is hampered by limited funding and growing demand from among an aging population, among other factors. These challenges have led to urgent calls to better support home care in Canada to ensure optimal use of scarce human and financial resources. One of the key strategies to achieve optimal use of resources may be remote monitoring of activities of daily living (ADLs), a type of telehealth. ADL telemonitoring can remotely recognize ADLs such as preparing meals and moving around the home. Past studies have shown that ADL telemonitoring can help in better understanding older adults' home care needs, thereby allowing for more personalized ADL interventions. Previous projects have also allowed for the developement of NEARS-SAPA, a telemonitoring system for ADLs. In these past projects, it was identified how NEARS-SAPA was used by home care services and its ease of use was tested in real environments. In the present project, the benefits of ADL telemonitoring will be tested and its technological capabilities expanded, hence preparing the system for the next big step, i.e. large-scale adoption by home care services. Ultimately, ADL telemonitoring may help the healthcare system determine which service is more appropriate for which person and at what time, thereby optimizing interventions and resource management.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Telemonitoring of ADL group | Experimental | Other: Telemonitoring of ADLWill receive the technology in their home to document if it influenced the homecare services plan. |
| No telemonitoring of ADL | No intervention | –Another group will be followed in therms of homecare services received, but without the technology. The control group will be gathered based on archives data only. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (1 listed)
- 1) be an older adult (> 65 years old), 2) have cognitive deficits as reported in the medical record, 3) live alone, at home, 4) be a care recipient of home care services, 5) speak French or English
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Telemonitoring of ADLTelemonitoring of ADL is based on smart environments sensors (non wearables) and gathers information about activity of daily living routines for a better understanding of homecare services needed. | Other | Telemonitoring of ADL group |
Primary outcome
Number of homecare services received to support activities of daily living (ADL)
Time frame: From enrollment until around 12 months of following.
Number of homecares ADL services received as identified in clinical databases.
Nature of homecare services received to support activities of daily living (ADL).
Time frame: From enrollement until around 12 months of following.
The category of services received related to ADL as indicated in clinical databases.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Oct 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Dementia
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Nathalie Bier, Ph.D. principal investigator
CRIUGM, Université de Montréal
Charles Gouin-Vallerand, Ph.D. principal investigator
Université de Sherbrooke
Kevin Bouchard, Ph.D. principal investigator
Université du Québec à Chicoutimi
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Telemonitoring of ADL in people with Dementia, run by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal at 3 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Maxime Lussier, Ph.D. (514-340-3540, maxime.lussier.ccsmtl@ssss.gouv.qc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of homecare services received to support activities of daily living (ADL) (time frame: From enrollment until around 12 months of following.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.